EMILEE CAMPBELL: Open Payments
NPI 1033562954 · LEXINGTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 18 payments from 9 companies in 2025. Trend: 2023 $141 · 2024 $400 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 5 | $96 |
| Exeltis, USA Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Organon LLC | 3 | $22 |
| Astellas Pharma US Inc | 1 | $21 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
| SHIELD THERAPEUTICS INC | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $18 |
Products named: MYFEMBREE, SLYND, Mirena, NEXPLANON, Veozah, INJECTAFER, Cologuard Collection Kit, ACCRUFER.
Industry payments across SC — which companies pay providers there.
